(Q34649077)

3 August 2017

1 reference

title

Gemcitabine-induced radiation recall (English)

1 reference

3 August 2017

9

Ravi Salgia

1 reference

3 August 2017

2

Pasi A Jänne

1 reference

3 August 2017

Melenda D Jeter

1

1 reference

3 August 2017

Sarah Brooks

3

1 reference

3 August 2017

Harold J Burstein

4

1 reference

3 August 2017

Patrick Wen

5

1 reference

3 August 2017

Charles S Fuchs

6

1 reference

3 August 2017

Jay S Loeffler

7

1 reference

3 August 2017

Phillip M Devlin

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

International Journal of Radiation Oncology Biology Physics

3 August 2017

published in

1 reference

3 August 2017

volume

53

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

394-400

1 reference

Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Potentiation of x-ray effects by actinomycin D

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Mucocutaneous reactions to antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiosensitizing nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall in a patient with breast cancer treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall--another call with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Sunlight-induced radiation recall

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation-recall enteritis after actinomycin-D and adriamycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Adriamycin and Enhanced Radiation Reaction in Normal Esophagus and Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation Recall Dermatitis Induced by Edatrexate in a Patient with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Paclitaxel-induced radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall induced by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Ultraviolet recall associated with etoposide and cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Mucocutaneous reactions to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

The "recall effect" in radiotherapy: is subeffective, reparable damage involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Visual complications following irradiation for pituitary adenomas and craniopharyngiomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Brainstem tolerance to conformal radiotherapy of skull base tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Paclitaxel-induced radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Taxol and radiation recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Paclitaxel and radiation-recall dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation-recall dermatitis in a patient treated with paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Docetaxel and radiation-recall severe mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall supraglottitis. A hazard in head and neck chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall reaction to idarubicin resulting in vaginal necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Adriamycin Activating a Recall Phenomenon After Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

1 reference

7 January 2021

Radiation-adriamycin interactions: Preliminary clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

"Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

Radiation recall and radiosensitization with alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902773-6

7 January 2021

10.1016/S0360-3016(02)02773-6

Identifiers

DOI

1 reference

3 August 2017

1 reference